Log in to save to my catalogue

Long COVID after breakthrough SARS-CoV-2 infection

Long COVID after breakthrough SARS-CoV-2 infection

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9307472

Long COVID after breakthrough SARS-CoV-2 infection

About this item

Full title

Long COVID after breakthrough SARS-CoV-2 infection

Publisher

New York: Nature Publishing Group US

Journal title

Nature medicine, 2022-07, Vol.28 (7), p.1461-1467

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

The post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection—also referred to as Long COVID—have been described, but whether breakthrough SARS-CoV-2 infection (BTI) in vaccinated people results in post-acute sequelae is not clear. In this study, we used the US Department of Veterans Affairs national healthcare d...

Alternative Titles

Full title

Long COVID after breakthrough SARS-CoV-2 infection

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9307472

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9307472

Other Identifiers

ISSN

1078-8956

E-ISSN

1546-170X

DOI

10.1038/s41591-022-01840-0

How to access this item